Trillium Announces Voting Results From the Annual General and Special Meeting of Shareholders
CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL) (the “Corporation”), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 8, 2021.
The results of the director elections were as follows:
About Trillium Therapeutics
For more information visit: www.trilliumtherapeutics.com
What Happens to SD-WAN in a SASE World?
ITEXPO #TECHSUPERSHOW Exhibit Hall Open
The Office Phone Reinvented (Again): Making Money with VoIP